Lifevantage Statistics
NASDAQ: LFVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.15-0.74 (-15.13%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Lifevantage by the numbers
Lifevantage has a market capitalization of $52.6 million based on 12.68M shares outstanding. Its trailing P/E ratio is 19.8, and its forward P/E is 27.7. The stock trades 28.0% below its 50-day average and 28.9% below its 200-day average.
Average daily trading volume is 45.72K shares, or about $189,750 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LFVN valuation vs. peer median
| Metric | LFVN | Peer median | Difference |
|---|---|---|---|
| Market cap | $52.63M | $53.00M | -1% |
| Avg. volume | 45.72K | 114.54K | -60% |
Peer median across 8 companies: XBIT, CTOR, XLO, ALDX, CLNN, BOLD, AZR, ACRV.
Valuation
- Market cap
- $52.63M
- P/E (TTM)
- 19.76
- Forward P/E
- 27.67
- Price / sales (latest FY)
- 0.29
- EPS (TTM)
- $0.21
- Shares outstanding
- 12.68M
Price and trading
- Previous close
- 4.89
- Open
- 4.76
- Day range
- 4.00 – 4.93
- 52-week range
- 3.90 – 11.71
- 52-week change
- -35.46%
- Beta
- —
- Volume
- 72.94K
- Average volume
- 45.72K
Dividends and events
- Annual dividend
- $0.19
- Dividend yield
- 4.58%
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 52.63M
- Pe
- 19.76
- Forward Pe
- 27.67
- Eps
- 0.21
- Dividend Yield
- 4.72%
- Dividend Rate
- 0.19
- Week52 High
- 11.71
- Week52 Low
- 3.90
- Avg Volume
- 45,723.00
- Shares Outstanding
- 12.68M
- Ma50
- 5.76
- Ma200
- 5.84
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -64.56%
- Pct From52w Low
- 6.41%